| Literature DB >> 32203502 |
Patrícia Deps1,2, João Marcelo Antunes3, Adalberto Rezende Santos4, Simon M Collin5.
Abstract
Understanding the prevalence of M. leprae infection in armadillos is important because of evidence from Brazil and other countries of an association between contact with armadillos and the development of Hansen's Disease (leprosy). Our aim was to characterize studies which have investigated natural M. leprae infection in wild armadillos in Brazil, and to quantify and explore variability in the reported prevalence of infection. We conducted a systematic review (PROSPERO CRD42019155277) of publications in MEDLINE, EMBASE, Global Health, Scopus, LILACS, Biblioteca Digital Brasileira de Teses e Dissertações, Catálogo de Teses e Dissertações de CAPES, and Biblioteca Virtual em Saúde up to 10/2019 using Mesh and text search terms (in English, Portuguese, Spanish, and French). The 10 included studies represented a total sample of 302 armadillos comprising 207 (69%) Dasypus novemcinctus, 67 (22%) Euphractus sexcinctus, 16 (5%) Priodontes maximus, 10 (3%) Cabassous unicinctus, and 2 (1%) Cabassous tatouay from 7 different states. Methods used included histopathology (4 studies), PGL-1 and LID-1 antigen detection (4 studies) and examination for clinical signs of disease (4 studies). Eight studies used PCR of which 7 targeted the RLEP repetitive element and 3 tested for inhibitory substances. M. leprae prevalence by PCR ranged from 0% (in 3 studies) to 100% in one study, with a summary estimate of 9.4% (95% CI 0.4% to 73.1%) and a predictive interval of 0-100%. The average prevalence is equivalent to 1 in 10 armadillos in Brazil being infected with M. leprae, but wide variation in sample estimates means that the prevalence in any similar study would be entirely unpredictable. We propose instead that future studies aim to investigate transmission and persistence of M. leprae within and between armadillo populations, meanwhile adopting the precautionary principle to protect human health and an endangered species in Brazil.Entities:
Year: 2020 PMID: 32203502 PMCID: PMC7156091 DOI: 10.1371/journal.pntd.0008127
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Main characteristics and findings of included studies investigating M. leprae infection in wild armadillos in Brazil.
| Author | Year | Location | Ref | Armadillo species | Total number caught | Test method(s) | Positive animals (tissue) | Positive animals (blood) | Test method details |
|---|---|---|---|---|---|---|---|---|---|
| Deps | 2003 | Espírito Santo | [ | 52 | PCR | 19/36 (53%) | 5/42 (12%) | single-round 65 kDa (+ Southern Blot Hybridization) | |
| 52 | BCG, HE, ZN | 0/47 (BCG) 0/48 (HE) 0/50 (ZN) | Ear tissue | ||||||
| Deps | 2007 | Espírito Santo | [ | 52 | ILF | - | 11/37 (30%) | PGL-1 rapid test | |
| Deps | 2008 | Espírito Santo | [ | 66 | ELISA | - | 5/47 (11%) | PGL-1 IgM | |
| Antunes | 2007 | Espírito Santo | [ | 65 | PCR | 4/65 (6%) | - | single-round 18kDa, RLEP (+ qPCR + sequencing) | |
| Pedrini | 2010 | São Paulo + Mato Grosso do Sul | [ | 18 | PCR | 0/18 | 0/2 | single-round RLEP (+ MegaBACE 1000 sequencing) | |
| 22 | PCR | 0/22 | 0/19 | single-round RLEP (+ MegaBACE 1000 sequencing) | |||||
| 2 | PCR | 0/2 | 0/2 | single-round RLEP (+ MegaBACE 1000 sequencing) | |||||
| 2 | PCR | 0/2 | 0/2 | single-round RLEP (+ MegaBACE 1000 sequencing) | |||||
| All species as above | 44 | ZN | 0/44 | - | |||||
| Frota | 2012 | Ceará | [ | 27 | PCR | 5/27 (19%) | - | nested RLEP | |
| 2 | PCR | 1/2 (50%) | - | nested RLEP | |||||
| de Souza | 2016 | Mato Grosso do Sul | [ | 16 | PCR | 0/16 | - | single-round RLEP (+ qPCR + mPCR + VNTR) | |
| 17 + 6 | PCR | 0/23 | - | single-round RLEP (+ qPCR + mPCR + VNTR) | |||||
| 2 + 1 | PCR | 0/3 | - | single-round RLEP (+ qPCR + mPCR + VNTR) | |||||
| 8 | PCR | 0/8 | - | single-round RLEP (+ qPCR + mPCR + VNTR) | |||||
| da Silva | 2018 | Pará | [ | 16 | PCR | 10/16 (63%) | - | single-round RLEP (+ WGS) | |
| Stefani | 2019 | Amazonas | [ | 12 | PCR | 0/12 | - | single-round RLEP | |
| 12 | HE, FF | 0/12 | - | ||||||
| da Silva Ferreira | 2020 | Rio Grande do Norte | [ | 20 | PCR | 20/20 | - | nested RLEP | |
| 20 | ELISA, ILF | - | 20/20 | PGL-1 IgM, LID-1 IgG |
a BCG = Bacillus Calmette–Guérin (antigen immunohistochemistry); ELISA = enzyme-linked immunosorbent assay; FF = Fite Faraco; HE = haematoxylin and eosin stain; ILF = immunochromatographic lateral flow test; PCR = Polymerase Chain Reaction (mPCR = multiplex PCR; qPCR = Real Time PCR); PGL-1 = phenolic glycolipid 1; RFLP = restriction fragment length polymorphism analysis; RLEP = M. leprae-specific repetitive element; VNTR = variable number tandem repeat (genotyping); WGS = whole genome sequencing; ZN = Ziehl-Neelsen (bacilloscopy)
b Four studies investigated clinical signs of leprosy, two with positive findings (Deps [23] and Antunes [7]), one negative (de Souza [28]) and one inconclusive (Stefani et al [10])
c Deps reported ML Flow rapid immunochromatographic serology (PGL-1) results in Deps et al 2007 [26] and ELISA (PGL-1) results in Deps et al 2008 [27]
d the analysed samples belonged to the gyrAT (SNP type 3) population, which was also identified in wild armadillos in the USA [29] and in humans in Brazil [30]
e roadkill animals
f da Silva et al used SYBR Gold and auramine/rhodamine staining techniques (staining of mycobacteria in situ), detection of PGL-1 antigen using polyclonal rabbit antibody and acid-fast staining of bacilli using HE and FF techniques in spleen sections from PCR-positive wild armadillos, but total numbers of samples tested using these techniques and overall concordance with PCR results was not reported [3]
g Following complete dermato-neurological examination by a dermatologist, skin lesions suspect of leprosy were biopsied. Skin sections were further prepared for histopathological examination after HE and FF staining for bacilli identification. 48 skin sections on 96 slides were tested, all were negative, but one armadillo showed skin histopathology compatible with paucibacillary leprosy, another showed granulomas with epithelioid and Langerhans cells [10]
h ELISA IgM against PGL-1 and IgG against LID-1 antigens; NDO-LID rapid ILF test (Orange Life, Rio de Janeiro, Brazil); ML Flow ILF test (acquired from Dr. Samira Bührer-Sékula, Royal Tropical Institute, KIT Biomedical Research, Amsterdam, the Netherlands)
inh inhibitory substances tested for in negative DNA samples